Nilotinib Zentiva is a medicine used to treat a type of blood cancer called chronic myeloid leukemia (CML), where the body produces too many abnormal white blood cells.
For newly diagnosed CML, the recommended dose is 600 mg per day (two 150 mg capsules twice daily). If previous treatment is no longer effective, the recommended dose is 800 mg per day (two 200 mg capsules twice daily).
Swallow the capsules whole with water. Do not eat any food for 2 hours before or 1 hour after taking the medicine. Do not open the capsules.
The maximum daily dose for children and adolescents is 800 mg. For adults, the dose is 600 mg or 800 mg depending on the condition.